Interaction of the Lyme disease spirochete Borrelia burgdorferi with brain parenchyma elicits inflammatory mediators from glial cells as well as glial and neuronal apoptosis.

Lyme neuroborreliosis, caused by the spirochete Borrelia burgdorferi, often manifests by causing neurocognitive deficits. As a possible mechanism for Lyme neuroborreliosis, we hypothesized that B. burgdorferi induces the production of inflammatory mediators in the central nervous system with concomitant neuronal and/or glial apoptosis. To test our hypothesis, we constructed an ex vivo model that consisted of freshly collected slices from brain cortex of a rhesus macaque and allowed live B. burgdorferi to penetrate the tissue. Numerous transcripts of genes that regulate inflammation as well as oligodendrocyte and neuronal apoptosis were significantly altered as assessed by DNA microarray analysis. Transcription level increases of 7.43-fold (P = 0.005) for the cytokine tumor necrosis factor-alpha and 2.31-fold (P = 0.016) for the chemokine interleukin (IL)-8 were also detected by real-time-polymerase chain reaction array analysis. The immune mediators IL-6, IL-8, IL-1beta, COX-2, and CXCL13 were visualized in glial cells in situ by immunofluorescence staining and confocal microscopy. Concomitantly, significant proportions of both oligodendrocytes and neurons undergoing apoptosis were present in spirochete-stimulated tissues. IL-6 production by astrocytes in addition to oligodendrocyte apoptosis were also detected, albeit at lower levels, in rhesus macaques that had received in vivo intraparenchymal stereotaxic inoculations of live B. burgdorferi. These results provide proof of concept for our hypothesis that B. burgdorferi produces inflammatory mediators in the central nervous system, accompanied by glial and neuronal apoptosis.

[1]  J. Radolf,et al.  Phagocytosis of Borrelia burgdorferi, the Lyme Disease Spirochete, Potentiates Innate Immune Activation and Induces Apoptosis in Human Monocytes , 2007, Infection and Immunity.

[2]  H. Pfister,et al.  Borrelia garinii Induces CXCL13 Production in Human Monocytes through Toll-Like Receptor 2 , 2007, Infection and Immunity.

[3]  D. Cadavid The mammalian host response to borrelia infection , 2006, Wiener klinische Wochenschrift.

[4]  R. Fujinami,et al.  The pathologic role for COX-2 in apoptotic oligodendrocytes in virus induced demyelinating disease: Implications for multiple sclerosis , 2006, Journal of Neuroimmunology.

[5]  M. Schwaninger,et al.  Subarachnoid hemorrhage due to Borrelia burgdorferi‐associated vasculitis , 2006, European journal of neurology.

[6]  W. Griffin,et al.  Inflammation and neurodegenerative diseases. , 2006, The American journal of clinical nutrition.

[7]  W. Friedman Interactions of interleukin-1 with neurotrophic factors in the central nervous system , 2005, Molecular Neurobiology.

[8]  M. Philipp,et al.  Pathogenesis of Lyme neuroborreliosis: Mitogen-activated protein kinases Erk1, Erk2, and p38 in the response of astrocytes to Borrelia burgdorferi lipoproteins , 2005, Neuroscience Letters.

[9]  H. Pfister,et al.  The chemokine CXCL13 (BLC): A putative diagnostic marker for neuroborreliosis , 2005, Neurology.

[10]  U. Gómez-Pinedo,et al.  Proinflammatory cytokines and apoptosis following glutamate-induced excitotoxicity mediated by p38 MAPK in the hippocampus of neonatal rats , 2005, Journal of Neuroimmunology.

[11]  P. Fitzgerald-Bocarsly,et al.  The nervous system as ectopic germinal center: CXCL13 and IgG in lyme neuroborreliosis , 2005, Annals of neurology.

[12]  R. Quirion,et al.  Up‐regulation of interleukin‐6 induced by prostaglandin E2 from invading macrophages following nerve injury: an in vivo and in vitro study , 2005, Journal of neurochemistry.

[13]  A. Gautam,et al.  Expression of the bmpB Gene of Borrelia burgdorferi Is Modulated by Two Distinct Transcription Termination Events , 2005, Journal of bacteriology.

[14]  M. Sawada,et al.  Inflammatory process in Parkinson's disease: role for cytokines. , 2005, Current pharmaceutical design.

[15]  A. Lackner,et al.  Visualizing Cytokine-Secreting Cells In Situ in the Rhesus Macaque Model of Chronic Gut Inflammation , 2005, Clinical Diagnostic Laboratory Immunology.

[16]  J. Zajkowska,et al.  Concentrations of Macrophage Inflammatory Proteins MIP-1α and MIP-1β and Interleukin 8 (Il-8) in Lyme Borreliosis , 2004, Infection.

[17]  Deepak Kaushal,et al.  Analyzing and Visualizing Expression Data with Spotfire , 2004, Current protocols in bioinformatics.

[18]  L. Minghetti Cyclooxygenase‐2 (COX‐2) in Inflammatory and Degenerative Brain Diseases , 2004, Journal of neuropathology and experimental neurology.

[19]  D. Srinivasan,et al.  Cell Type-Specific Interleukin-1β Signaling in the CNS , 2004, The Journal of Neuroscience.

[20]  J. Zajkowska,et al.  [Evaluation of proinflammatory cytokine (TNF-alpha, IL-1beta, IL-6, IFN-gamma) concentrations in serum and cerebrospinal fluid of patients with neuroborreliosis]. , 2004, Neurologia i neurochirurgia polska.

[21]  S. Barthold,et al.  Spinal cord involvement in the nonhuman primate model of Lyme disease , 2004, Laboratory Investigation.

[22]  S. Haber The primate basal ganglia: parallel and integrative networks , 2003, Journal of Chemical Neuroanatomy.

[23]  B. Sander,et al.  Phenotypes indicating cytolytic properties of Borrelia-specific interferon-γ secreting cells in chronic Lyme neuroborreliosis , 2003, Journal of Neuroimmunology.

[24]  C. Godson,et al.  Phagocytosis of apoptotic cells and the resolution of inflammation. , 2003, Biochimica et biophysica acta.

[25]  V. Dennis,et al.  Pathogenesis of Lyme neuroborreliosis: Borrelia burgdorferi lipoproteins induce both proliferation and apoptosis in rhesus monkey astrocytes , 2003, European journal of immunology.

[26]  Y. Imai,et al.  Interleukin‐1β promotes oligodendrocyte death through glutamate excitotoxicity , 2003, Annals of neurology.

[27]  M. Wiranowska,et al.  Role and Mechanisms of Interleukin-1 in the Modulation of Neurotoxicity , 2003, Neuroimmunomodulation.

[28]  I. Marriott,et al.  Borrelia burgdorferi induces inflammatory mediator production by murine microglia , 2002, Journal of Neuroimmunology.

[29]  J. Ernerudh,et al.  Cytokines in Lyme borreliosis: lack of early tumour necrosis factor‐α and transforming growth factor‐β1 responses are associated with chronic neuroborreliosis , 2002 .

[30]  K. Narayan,et al.  Increased expression of B-lymphocyte chemoattractant, but not pro-inflammatory cytokines, in muscle tissue in rhesus chronic Lyme borreliosis. , 2002, Cytokine.

[31]  W. Pearson,et al.  Current Protocols in Bioinformatics , 2002 .

[32]  V. Sasseville,et al.  Enhanced Expression of Proinflammatory Cytokines in the Central Nervous System Is Associated with Neuroinvasion by Simian Immunodeficiency Virus and the Development of Encephalitis , 2002, Journal of Virology.

[33]  R. Vink,et al.  Activation Of Cyclo‐Oxygenase‐2 Contributes To Motor And Cognitive Dysfunction Following Diffuse Traumatic Brain Injury In Rats , 2001, Clinical and experimental pharmacology & physiology.

[34]  A. Pachner The rhesus model of Lyme neuroborreliosis , 2001, Immunological reviews.

[35]  W. Friedman Cytokines Regulate Expression of the Type 1 Interleukin-1 Receptor in Rat Hippocampal Neurons and Glia , 2001, Experimental Neurology.

[36]  P. Anderson,et al.  TIA‐1 is a translational silencer that selectively regulates the expression of TNF‐α , 2000 .

[37]  D. Cadavid,et al.  Localization of Borrelia Burgdorferi in the Nervous System and Other Organs in a Nonhuman Primate Model of Lyme Disease , 2000, Laboratory Investigation.

[38]  O. White,et al.  A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi , 2000, Molecular microbiology.

[39]  P. Lewczuk,et al.  Intrathecal release of sICAM-1 into CSF in neuroborreliosis — increased brain-derived fraction , 2000, Journal of Neuroimmunology.

[40]  L. Hagberg,et al.  Astroglial and neuronal proteins in cerebrospinal fluid as markers of CNS involvement in Lyme neuroborreliosis , 1999, European journal of neurology.

[41]  W. Küker,et al.  Neuroborreliose mit ausgeprägter zerebraler Vaskulitis und multiplen Hirninfarkten , 1999, Der Nervenarzt.

[42]  G. Habicht,et al.  Pathogenesis of Lyme neuroborreliosis in the rhesus monkey: the early disseminated and chronic phases of disease in the peripheral nervous system. , 1998, The Journal of infectious diseases.

[43]  M. Moskowitz,et al.  Activation and Cleavage of Caspase-3 in Apoptosis Induced by Experimental Cerebral Ischemia , 1998, The Journal of Neuroscience.

[44]  S. Salzberg,et al.  Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi , 1997, Nature.

[45]  I. Ferrer,et al.  Identification of necrotic cell death by the TUNEL assay in the hypoxic-ischemic neonatal rat brain , 1997, Neuroscience Letters.

[46]  C. Hughes,et al.  Interleukin-6 is expressed at high levels in the CNS in Lyme neuroborreliosis , 1997, Neurology.

[47]  J. England,et al.  Mononeuropathy multiplex in rhesus monkeys with chronic lyme disease , 1997, Annals of neurology.

[48]  C. Koski,et al.  Subarachnoid hemorrhage in a patient with lyme disease , 1997, Neurology.

[49]  A. Compston,et al.  Review: Glial lineages and myelination in the central nervous system , 1997 .

[50]  H. Kalimo,et al.  Inflammatory brain changes in Lyme borreliosis. A report on three patients and review of literature. , 1996, Brain : a journal of neurology.

[51]  S. O'connell,et al.  Lyme myelitis mimicking neurological malignancy , 1996, The Lancet.

[52]  J. Merrill,et al.  Cytokines in inflammatory brain lesions: helpful and harmful , 1996, Trends in Neurosciences.

[53]  J. Clements,et al.  Neurovirulent Simian Immunodeficiency Virus Infection Induces Neuronal, Endothelial, and Glial Apoptosis , 1996, Molecular medicine.

[54]  L. Hagberg,et al.  Increased cerebrospinal fluid levels of glial fibrillary acidic protein (GFAp) in Lyme neuroborreliosis , 1996, Infection.

[55]  H. Link,et al.  Lyme Neuroborreliosis: Evidence for Persistent Up‐Regulation of Borrelia Burgdorferi‐Reactive Cells Secreting Interferon‐γ , 1995, Scandinavian journal of immunology.

[56]  N. Rothwell,et al.  Cytokines and the nervous system II: actions and mechanisms of action , 1995, Trends in Neurosciences.

[57]  J. Piesman,et al.  Chronic lyme disease in the rhesus monkey. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[58]  E. Major,et al.  Inoculation of nonhuman primates with the N40 strain of Borrelia burgdorferi leads to a model of lyme neuroborreliosis faithful to the human disease , 1995, Neurology.

[59]  Y. Gu,et al.  Early and early disseminated phases of Lyme disease in the rhesus monkey: a model for infection in humans , 1993, Infection and immunity.

[60]  J. Piesman Dynamics of Borrelia burgdorferi transmission by nymphal Ixodes dammini ticks. , 1993, The Journal of infectious diseases.

[61]  D. Dickson,et al.  Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease , 1993, Glia.

[62]  E. Benveniste Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. , 1992, The American journal of physiology.

[63]  G. Siggins,et al.  Interleukin-1β increases synaptic inhibition in rat hippocampal pyramidal neurons in vitro , 1992, Regulatory Peptides.

[64]  J. Benach,et al.  Cytokines and the pathogenesis of neuroborreliosis: Borrelia burgdorferi induces glioma cells to secrete interleukin-6. , 1991, The Journal of infectious diseases.

[65]  Jean Côté,et al.  Lyme Disease , 1991, International journal of dermatology.

[66]  Y. Kiso,et al.  Interleukin-1 beta inhibits long-term potentiation in the CA3 region of mouse hippocampal slices. , 1990, European journal of pharmacology.

[67]  R. Schmidt-Kastner,et al.  Immunohistochemistry of glial fibrillary acidic protein, vimentin and S-100 protein for study of astrocytes in hippocampus of rat. , 1990, Journal of chemical neuroanatomy.

[68]  A. Steere,et al.  The spirochetal etiology of Lyme disease. , 1983, The New England journal of medicine.

[69]  J. Zajkowska,et al.  Concentration of interferon-inducible T cell chemoattractant and monocyte chemotactic protein-1 in serum and cerebrospinal fluid of patients with Lyme borreliosis. , 2005, Roczniki Akademii Medycznej w Bialymstoku.

[70]  D. Srinivasan,et al.  Cell type-specific interleukin-1beta signaling in the CNS. , 2004, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[71]  K. Gustaw,et al.  Neurological and psychological symptoms after the severe acute neuroborreliosis. , 2001, Annals of Agricultural and Environmental Medicine.

[72]  J. García-Moncó,et al.  Spontaneous brain hemorrhage associated with Lyme neuroborreliosis. , 2001, Neurologia.

[73]  C. L. Jackson Brefeldin A revealing the fundamental principles governing membrane dynamics and protein transport. , 2000, Sub-cellular biochemistry.

[74]  G. Kreutzberg,et al.  Molecular signals for glial activation: pro- and anti-inflammatory cytokines in the injured brain. , 1999, Acta neurochirurgica. Supplement.

[75]  W. Küker,et al.  [Neuroborreliosis with extensive cerebral vasculitis and multiple cerebral infarcts]. , 1999, Der Nervenarzt.

[76]  A. Compston,et al.  Glial lineages and myelination in the central nervous system. , 1997, Journal of anatomy.

[77]  A. Stalder,et al.  Reactive gliosis as a consequence of interleukin-6 expression in the brain: studies in transgenic mice. , 1994, Developmental neuroscience.

[78]  R. Vink,et al.  ACTIVATION OF CYCLOOXYGENASE-2 CONTRIBUTES TO MOTOR AND COGNITIVE DYSFUNCTION FOLLOWING DIFFUSE TRAUMATIC BRAIN INJURY IN RATS , 2022 .